# Expanded Access to ABBV-787

> **NCT06439966** · — · NO_LONGER_AVAILABLE · sponsor: **AbbVie**

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** ABBV-787

## Key facts

- **NCT ID:** NCT06439966
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06439966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06439966, "Expanded Access to ABBV-787". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT06439966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*